ES8800052A1 - Un procedimiento para preparar una proteina de superficie antigenica de anaplasma marginale - Google Patents

Un procedimiento para preparar una proteina de superficie antigenica de anaplasma marginale

Info

Publication number
ES8800052A1
ES8800052A1 ES553307A ES553307A ES8800052A1 ES 8800052 A1 ES8800052 A1 ES 8800052A1 ES 553307 A ES553307 A ES 553307A ES 553307 A ES553307 A ES 553307A ES 8800052 A1 ES8800052 A1 ES 8800052A1
Authority
ES
Spain
Prior art keywords
daltons
antigenic surface
anaplasma marginale
surface protein
monoclonal antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES553307A
Other languages
English (en)
Other versions
ES553307A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Washington
Washington State University Research Foundation
Original Assignee
University of Washington
Washington State University Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Washington, Washington State University Research Foundation filed Critical University of Washington
Publication of ES8800052A1 publication Critical patent/ES8800052A1/es
Publication of ES553307A0 publication Critical patent/ES553307A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/29—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Richettsiales (O)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1246—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Rickettsiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

PROCEDIMIENTO PARA PREPARAR UNA PROTEINA DE SUPERFICIE ANTIGENICA DE ANAPLASMA MARGINALE. COMPRENDE: A) ROMPER ERITROCITOS DE BOVINO INFECTADOS CON CUERPOS INICIALES DE ANAPLASMA MARGINALES POR TRATAMIENTO CON ULTRASONIDOS; B) RECUPERAR CUERPOS INICIALES PURIFICADOS DE ANAPLASMA MARGINALE A PARTIR DE LOS ERITROCITOS ROTOS; C) ROMPER LOS CUERPOS INICIALES PURIFICADOS DE ANAPLASMA MARGINALES POR TRATAMIENTO CON UN DETERGENTE; D) HACER PASAR LOS CUERPOS INICIALES ROTOS A TRAVES DE UNA MATRIZ INSOLUBLE QUE TIENE ANTICUERPOS MONOCLONALES CONTRA UN DETERMINANTE EN UNA PROTEINA DE SUPERFICIE ANTIGENICA DE ANAPLASMA MARGINALE, PARA FIJAR SELECTIVAMENTE UNA PROTEINA DE SUERFICIE ANTIGENICA CON LOS ANTICUERPOS MONOCLONALES; Y E) RECUPERAR LA PROTEINA DE SUPERFICIE ANTIGENICA DE LA MATRIZ INSOLUBLE. LA PROTEINA DE SUPERFICIE ANTIGENA TIENE UN PESO MOLECULAR DE 105.000 DALTONES. SE UTILIZA PARA TRATAR LA ANAPLASMOSIS DEL GANADO VACUNO PROPIA DE REGIONES TROPICALES Y SUBTROPICALES DEL GLOBO TERRAQUEO.
ES553307A 1985-03-25 1986-03-24 Un procedimiento para preparar una proteina de superficie antigenica de anaplasma marginale Expired ES8800052A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71552885A 1985-03-25 1985-03-25
US76117885A 1985-07-31 1985-07-31

Publications (2)

Publication Number Publication Date
ES8800052A1 true ES8800052A1 (es) 1987-11-01
ES553307A0 ES553307A0 (es) 1987-11-01

Family

ID=27109363

Family Applications (1)

Application Number Title Priority Date Filing Date
ES553307A Expired ES8800052A1 (es) 1985-03-25 1986-03-24 Un procedimiento para preparar una proteina de superficie antigenica de anaplasma marginale

Country Status (9)

Country Link
EP (1) EP0196290A3 (es)
AU (1) AU5503986A (es)
CA (1) CA1272124A (es)
DK (1) DK138886A (es)
ES (1) ES8800052A1 (es)
GR (1) GR860772B (es)
IE (1) IE860758L (es)
NZ (1) NZ215576A (es)
PT (1) PT82263B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU644362B2 (en) * 1989-04-06 1993-12-09 Washington State University Research Foundation, Inc. Rickettsial antigens for vaccination and diagnosis
US5869335A (en) * 1995-08-25 1999-02-09 Regents Of The University Of Minnesota Method of growing rickettsiae in Ixodes scapularis tick cell culture and preparing antigens and vaccines of rickettsiae
US6939549B2 (en) * 2000-10-30 2005-09-06 The Board Of Regents For Oklahoma State University Immunoprotective recombinant antigen from anaplasma marginale, vaccine compositions and methods of use
US6979451B1 (en) 2000-10-30 2005-12-27 The Board Of Regents For Oklahoma State University Recombinant antigen MSP1a from anaplasma marginale to reduce infections in ticks, vaccine compositions and methods of use
BR0208588A (pt) * 2001-04-12 2004-03-23 Queensland Inst Med Res Antìgenos para despertar uma resposta imune contra patógenos de ehrilichieae e rickettsieae

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3511908A (en) * 1965-06-23 1970-05-12 Univ Oklahoma State Method of manufacturing anaplasmosis vaccine
EP0081575A4 (en) * 1981-06-22 1983-10-26 Univ Illinois ANTIGEN FOR ANAPLASMA.

Also Published As

Publication number Publication date
PT82263B (pt) 1988-07-29
IE860758L (en) 1986-09-25
EP0196290A2 (en) 1986-10-01
EP0196290A3 (en) 1989-02-15
CA1272124A (en) 1990-07-31
PT82263A (en) 1986-07-01
DK138886A (da) 1986-09-26
GR860772B (en) 1986-07-21
ES553307A0 (es) 1987-11-01
DK138886D0 (da) 1986-03-25
AU5503986A (en) 1986-10-02
NZ215576A (en) 1988-07-28

Similar Documents

Publication Publication Date Title
Young et al. Immunological activity of a 38-kilodalton protein purified from Mycobacterium tuberculosis
GR3026419T3 (en) Inducing antibody response against self-proteins with the aid of foreign t-cell epitopes
Britton et al. Immunoreactivity of a 70 kD protein purified from Mycobacterium bovis Bacillus Calmette-Guerin by monoclonal antibody affinity chromatography.
ATE127345T1 (de) Stressproteine und verwendungen dafür.
EP1630229A3 (en) Melanoma antigens
CA2290485A1 (en) Method for the production of non-immunogenic proteins
DE3855479D1 (de) Hiv-peptide, künstliche hiv-antigene und immuntestsätze
IE890853L (en) Monoclonal Antibodies
BR9810907A (pt) Anticorpos monoclonais e policlonais, peptìdeo suscetìvel de gerar um anticorpo, agente imunogênico, sequência de nucleotìdeos, composição farmacêutica, uso de pelo menos um anticorpo, kit de diagnóstico, e, processo para preparar um agente imunogênico
WO1996021734A3 (en) P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods
Brett et al. Differential pattern of T cell recognition of the 65‐kDa mycobacterial antigen following immunization with the whole protein or peptides
Child et al. A review of the applications of immunochemistry to archaeological bone
WO1999013907A3 (en) Methods to improve immunogenicity of antigens and specificity of antibodies
SE9001105D0 (sv) New methods foer diagnosis of tuberculosis
ES8800052A1 (es) Un procedimiento para preparar una proteina de superficie antigenica de anaplasma marginale
DE3887750D1 (de) Selektive entfernung von immunkomplexen.
AU625171B2 (en) Specific excretion-secretion antigens of toxoplasma gondii, their expression products, processes for obtaining them and their diagnostic and prophylactic uses
Pike et al. Chromatographic analysis and sulfhydryl sensitivity of antileptospira agglutinins in rabbit and human sera.
ZA93123B (en) Peptides representing fragments of CMP, antibodies directed against the said peptides, and their uses
Mitani et al. Immunoglobulin E-suppressing and immunoglobulin G-enhancing tetanus toxoid prepared by conjugation with pullulan
Fritz et al. Specificity of antisera from Lewis rats immunized with encephalitogenic fragment 43–88 of guinea pig myelin basic protein
Harboe et al. Carrier Effect of Concanavalin A‐Reactive and‐Non‐Reactive Material in Tuberculin PPD
Ekpo et al. Monoclonal antibodies to 52-kilodalton protein of Salmonella typhi
Tirrell Studies of guinea pig immunoglobulin isotype, idiotype and antiidiotype.
BASTEN The characterization and immunoreactivity of a 70 KD protein common to Mycobacteri· um Jeprae and Mycobacterium bovis (BeG)

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970519